LTC Intermediate Nursing Care

Intermediate nursing care is a level of care provided in long-term care (LTC) facilities for patients who require assistance with daily living activities, but not to the extent required by skilled nursing care. It is typically provided by licensed practical nurses (LPNs) or certified nursing assistants (CNAs).

Here are some key features of LTC intermediate nursing care:

• Definition: Intermediate nursing care is a level of care that falls between skilled nursing care and custodial care. It is designed for patients who require some assistance with daily living activities, but not to the extent required by skilled nursing care.

• Services: Intermediate nursing care services may include assistance with bathing, dressing, eating, and medication management, as well as physical therapy, occupational therapy, and speech therapy. The goal is to help patients maintain their independence and improve their quality of life.

• Setting: Intermediate nursing care is typically provided in LTC facilities, such as nursing homes or assisted living facilities.

• Payment: Payment for intermediate nursing care may come from a variety of sources, including private insurance, Medicaid, or out-of-pocket payments.

• Coverage: Coverage for intermediate nursing care varies depending on the insurance plan. Some plans may cover all or part of the costs, while others may have limitations or exclusions.

• Eligibility: Eligibility for intermediate nursing care may depend on the patient's medical condition and level of need. A physician or other healthcare professional may need to assess the patient's needs and determine the appropriate level of care.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.